Immunohistochemical expression of glucose transporters in the peritumoral area of patients with glioblastomas: a pilot study

BACKGROUND: Glioblastomas remain among the most aggressive tumors, characterized by a high degree of malignancy and a poor prognosis. Despite advances in diagnostic and therapeutic methods, patient survival with this disease remains low. Key factors include tumor cell energy metabolism, particularly in the peritumoral zone, where tumor boundaries are blurred and invasiveness and growth processes play a key role. Studying the expression of GLUT1 and GLUT3 glucose transporters in this region may help better understand the characteristics of metabolic activity and tumor progression. AIM: The aim of this study was to determine the relationships between immunohistochemical expression of glucose transporters in the peritumoral zone and morphological parameters of malignancy and time to progression after primary surgery in patients with glioblastomas. METHODS: This study is a retrospective, diagnostic, observational study. Archival surgical material was used. The study included a detailed histological assessment of tumor tissue parameters using morphometric approaches and immunohistochemical staining for the glucose transporters GLUT1 and GLUT3 in the peritumoral zone, as well as control markers. Digital scanners and morphometric programs were used to assess expression, and the data were analyzed based on morphological features of malignancy and time to progression after surgery using statistical methods. RESULTS: The study included 34 patients with grade 4 glioblastoma who relapsed after primary surgery. The most consistent morphological parameters of malignancy were mitotic activity, cell density, and necrotic changes, while cellular atypia was the most consistent parameter, and pseudopalisading structures and vascular proliferation were the least consistent. Immunohistochemical analysis revealed variable, but predominantly elevated, cytoplasmic expression of GLUT1 and GLUT3. Correlation analysis revealed the most significant associations for GLUT1 with cellularity only (р=0,001), while GLUT3 had the most significant associations with both cellularity and mitotic activity (р=10-4). Time to progression was significantly associated with both glucose transporters (р=10-4), indicating their importance as prognostic markers. CONCLUSION: The study demonstrates that peritumoral glucose transporter expression levels can serve as an important marker of initial proliferative transformation and prognostic characteristics of glioblastomas. Their use allows for a more accurate assessment of tumor invasive potential and prognosis of the disease course. However, limitations associated primarily with the complexity of the preanalytical stage and the demanding accuracy of the study itself must be kept in mind.

Authors

Institutions

Publication Details

Journal
Morphology
Published
2026-11-19
DOI
https://doi.org/10.17816/morph.702585
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immunohistochemical expression of glucose transporters in the peritumoral area of patients with glioblastomas: a pilot study

N.Yu. Orlinskaya, Яшин Константин Сергеевич, Artem Grishin, Igor Aleksandrovich Medyanik et al.
Morphology
Glioma Diagnosis and Treatment
article

Immunohistochemical expression of glucose transporters in the peritumoral area of patients with glioblastomas: a pilot study

N.Yu. Orlinskaya, Яшин Константин Сергеевич, Artem Grishin, Igor Aleksandrovich Medyanik, Marina V. Shirmanova, Daria A. Sachkova, Veronica. V. Antoshina, L. S. Kukhnina, Svetlana Korikova, Evgeny Klyuev
article en

Abstract

BACKGROUND: Glioblastomas remain among the most aggressive tumors, characterized by a high degree of malignancy and a poor prognosis. Despite advances in diagnostic and therapeutic methods, patient survival with this disease remains low. Key factors include tumor cell energy metabolism, particularly in the peritumoral zone, where tumor boundaries are blurred and invasiveness and growth processes play a key role. Studying the expression of GLUT1 and GLUT3 glucose transporters in this region may help better understand the characteristics of metabolic activity and tumor progression. AIM: The aim of this study was to determine the relationships between immunohistochemical expression of glucose transporters in the peritumoral zone and morphological parameters of malignancy and time to progression after primary surgery in patients with glioblastomas. METHODS: This study is a retrospective, diagnostic, observational study. Archival surgical material was used. The study included a detailed histological assessment of tumor tissue parameters using morphometric approaches and immunohistochemical staining for the glucose transporters GLUT1 and GLUT3 in the peritumoral zone, as well as control markers. Digital scanners and morphometric programs were used to assess expression, and the data were analyzed based on morphological features of malignancy and time to progression after surgery using statistical methods. RESULTS: The study included 34 patients with grade 4 glioblastoma who relapsed after primary surgery. The most consistent morphological parameters of malignancy were mitotic activity, cell density, and necrotic changes, while cellular atypia was the most consistent parameter, and pseudopalisading structures and vascular proliferation were the least consistent. Immunohistochemical analysis revealed variable, but predominantly elevated, cytoplasmic expression of GLUT1 and GLUT3. Correlation analysis revealed the most significant associations for GLUT1 with cellularity only (р=0,001), while GLUT3 had the most significant associations with both cellularity and mitotic activity (р=10-4). Time to progression was significantly associated with both glucose transporters (р=10-4), indicating their importance as prognostic markers. CONCLUSION: The study demonstrates that peritumoral glucose transporter expression levels can serve as an important marker of initial proliferative transformation and prognostic characteristics of glioblastomas. Their use allows for a more accurate assessment of tumor invasive potential and prognosis of the disease course. However, limitations associated primarily with the complexity of the preanalytical stage and the demanding accuracy of the study itself must be kept in mind.

Morphology
Privolzhsky Research Medical University (RU)
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon